This study aimed to investigate the short-term trajectory of peripheral neuropathy in patients receiving triweekly albumin-bound paclitaxel (nab-paclitaxel) chemotherapy. 235 patients were recruited from March to August 2024, of whom 65.1% developed neuropathy... ...

请注册登录后继续浏览